Literature DB >> 16684964

Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2.

Elke Heiss1, Kristina Masson, Christina Sundberg, Malin Pedersen, Jianmin Sun, Susanne Bengtsson, Lars Rönnstrand.   

Abstract

Early signal relay steps upon ligand binding to the receptor tyrosine kinase Flt3 (ie, sites of Flt3 autophosphorylation and subsequent docking partners) are mainly unresolved. By immunoprecipitation of specific tryptic peptides contained in the juxtamembrane region of human Flt3 and subsequent radiosequencing, we identified the tyrosine residues 572, 589, 591, and 599 as in vivo autophosphorylation sites. Focusing on Y589 and Y599, we examined Flt3 ligand (FL)-mediated responses in wild-type-Flt3-(WT-Flt3-), Y589F-Flt3-, and Y599F-Flt3-expressing 32D cells. Compared with WT-Flt3-32D cells upon ligand stimulation, 32D-Y589F-Flt3 showed enhanced Erk activation and proliferation/survival, whereas 32D-Y599F-Flt3 cells hereby displayed substantially diminished responses. Both pY589 and pY599 were identified as association sites for signal relay molecules including Src family kinases and SHP2. Consistently, 32D-Y589F-Flt3 and 32D-Y599F-Flt3 showed decreased FL-triggered activation of Src family kinases. Interference with the Src-dependent negative regulation of Flt3 signaling may account for the enhanced mitogenic response of Y589F-Flt3. Y599 was additionally found to interact with the protein tyrosine phosphatase SHP2 in a phosphorylation-dependent manner. As Y599F-Flt3-32D was unable to associate with and to phosphorylate SHP2 and since silencing of SHP2 in WT-Flt3-expressing cells mimicked the Y599F-Flt3 phenotype, we hypothesize that recruitment of SHP2 to pY599 contributes to FL-mediated Erk activation and proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684964     DOI: 10.1182/blood-2005-07-008896

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

Review 1.  Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Lars Rönnstrand
Journal:  Med Oncol       Date:  2013-10-31       Impact factor: 3.064

2.  A conserved threonine residue in the juxtamembrane domain of the XA21 pattern recognition receptor is critical for kinase autophosphorylation and XA21-mediated immunity.

Authors:  Xuewei Chen; Mawsheng Chern; Patrick E Canlas; Caiying Jiang; Deling Ruan; Peijian Cao; Pamela C Ronald
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

3.  Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.

Authors:  Julhash U Kazi; Lars Rönnstrand
Journal:  Mol Oncol       Date:  2013-03-19       Impact factor: 6.603

Review 4.  Differential signaling of Flt3 activating mutations in acute myeloid leukemia: a working model.

Authors:  Perry M Chan
Journal:  Protein Cell       Date:  2011-02-25       Impact factor: 14.870

5.  Identifying three-dimensional structures of autophosphorylation complexes in crystals of protein kinases.

Authors:  Qifang Xu; Kimberly L Malecka; Lauren Fink; E Joseph Jordan; Erin Duffy; Samuel Kolander; Jeffrey R Peterson; Roland L Dunbrack
Journal:  Sci Signal       Date:  2015-12-01       Impact factor: 8.192

6.  Protein-tyrosine phosphatase DEP-1 controls receptor tyrosine kinase FLT3 signaling.

Authors:  Deepika Arora; Sabine Stopp; Sylvia-Annette Böhmer; Julia Schons; Rinesh Godfrey; Kristina Masson; Elena Razumovskaya; Lars Rönnstrand; Simone Tänzer; Reinhard Bauer; Frank-D Böhmer; Jörg P Müller
Journal:  J Biol Chem       Date:  2011-01-24       Impact factor: 5.157

7.  FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia.

Authors:  Julhash U Kazi; Lars Rönnstrand
Journal:  Mol Oncol       Date:  2012-11-29       Impact factor: 6.603

8.  Flt3L is a novel regulator of skeletal myogenesis.

Authors:  Yejing Ge; Rachel J Waldemer; Ramakrishna Nalluri; Paul D Nuzzi; Jie Chen
Journal:  J Cell Sci       Date:  2013-05-23       Impact factor: 5.285

9.  BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3.

Authors:  Amanda Nordigården; Maria Kraft; Pernilla Eliasson; Verena Labi; Eric W-F Lam; Andreas Villunger; Jan-Ingvar Jönsson
Journal:  Blood       Date:  2008-12-08       Impact factor: 22.113

Review 10.  Structural and functional alterations of FLT3 in acute myeloid leukemia.

Authors:  Soheil Meshinchi; Frederick R Appelbaum
Journal:  Clin Cancer Res       Date:  2009-06-23       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.